Penumbra (PEN) Operating Income Growth (1y) (2015 - 2026)
Penumbra (PEN) Operating Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | 74.18% |
| 10 | Penumbra | 12.58 Bn | 11.97 Bn | 253.41 Mn | -5.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.24% |
| Dec 31, 2025 | 38.48% |
| Sep 30, 2025 | 38.10% |
| Jun 30, 2025 | 150.43% |
| Mar 31, 2025 | 233.44% |
| Dec 31, 2024 | 22.11% |
| Sep 30, 2024 | 180.11% |
| Jun 30, 2024 | -552.57% |
| Mar 31, 2024 | 51.11% |
| Dec 31, 2023 | 624.79% |
| Sep 30, 2023 | 132.33% |
| Jun 30, 2023 | 12,969.78% |
| Mar 31, 2023 | 297.92% |
| Dec 31, 2022 | 112.07% |
| Sep 30, 2022 | -38.12% |
| Jun 30, 2022 | -101.35% |
| Mar 31, 2022 | -130.05% |
| Dec 31, 2021 | -2,195.53% |
| Sep 30, 2021 | 143.56% |
| Jun 30, 2021 | 158.43% |